Grant: Project Grant
Sunnybrook Research Institute (Toronto, Ontario)
$1,185,750.00
Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT).
EF 2016-17
Résumé
Lactoferrin is a whey protein found in breast milk. Bovine lactofferin is very similar to human lactoferrin. Recent studies have suggested that giving bovine lactoferrin to preterm infants with a birthweight < 1500 grams on a daily basis for a minimum of 2 weeks or until they reach 34 weeks gestational age will help reduce major problems such as chronic lung disease, severe retinopathy of prematurity, late onset infections and death.
This trial will recruit 500 preterm infants and will join an international collaborative to answer the important question related to bovine lactoferrin and its role in minimising neonatal illnesses.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
355867
Name
Asztalos Elizabeth V
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Project Grant Competition
Projecttitle
Does bovine lactoferrin (bLF) improve morbidity-free survival and severe retinopathy in very low birthweight infants? The Lactoferrin Infant Feeding Trial (LIFT).
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$1,185,750
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Bovine Lactoferrin; Neonatal Morbidities; Neonatal Survival; Preterm Infants
Abstract
Lactoferrin is a whey protein found in breast milk. Bovine lactofferin is very similar to human lactoferrin. Recent studies have suggested that giving bovine lactoferrin to preterm infants with a birthweight < 1500 grams on a daily basis for a minimum of 2 weeks or until they reach 34 weeks gestational age will help reduce major problems such as chronic lung disease, severe retinopathy of prematurity, late onset infections and death.
This trial will recruit 500 preterm infants and will join an international collaborative to answer the important question related to bovine lactoferrin and its role in minimising neonatal illnesses.
Competitiondate
201610
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Asztalos, Elizabeth V; Barrington, Keith J; Lodha, Abhay K; Tarnow-Mordi, William
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,185,750~ $0~
